Literature DB >> 1321422

Cloned human neuropeptide Y receptor couples to two different second messenger systems.

H Herzog1, Y J Hort, H J Ball, G Hayes, J Shine, L A Selbie.   

Abstract

Neuropeptide Y (NPY) is one of the most abundant neuropeptides in the mammalian nervous system and exhibits a diverse range of important physiological activities, including effects on psychomotor activity, food intake, regulation of central endocrine secretion, and potent vasoactive effects on the cardiovascular system. Two major subtypes of NPY receptor (Y1 and Y2) have been defined by pharmacological criteria. We report here the molecular cloning of a cDNA sequence encoding a human NPY receptor and the corrected sequence for a rat homologue. Analysis of this sequence confirms that the receptor is a member of the G protein-coupled receptor superfamily. When expressed in Chinese hamster ovary (CHO) or human embryonic kidney (293) cells, the receptor exhibits the characteristic ligand specificity of a Y1 type of NPY receptor. In the 293 cell line, the receptor is coupled to a pertussis toxin-sensitive G protein that mediates the inhibition of cyclic AMP accumulation. In the CHO cell line, the receptor is coupled not to the inhibition of adenylate cyclase but rather to the elevation of intracellular calcium. These results demonstrate that second messenger coupling of the NPY-Y1 receptor is cell type specific, depending on the specific repertoire of G proteins and effector systems present in any cell type.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321422      PMCID: PMC402104          DOI: 10.1073/pnas.89.13.5794

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family.

Authors:  C Eva; K Keinänen; H Monyer; P Seeburg; R Sprengel
Journal:  FEBS Lett       Date:  1990-10-01       Impact factor: 4.124

2.  [Pro34]neuropeptide Y selectively identifies postjunctional-mediated actions of neuropeptide Y in vivo in rats and dogs.

Authors:  E K Potter; J Fuhlendorff; T W Schwartz
Journal:  Eur J Pharmacol       Date:  1991-01-25       Impact factor: 4.432

3.  The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosome localization, and isolation of cDNA from tracheal and gastric tissues.

Authors:  N P Gerard; R L Eddy; T B Shows; C Gerard
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

4.  Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase.

Authors:  L Aakerlund; U Gether; J Fuhlendorff; T W Schwartz; O Thastrup
Journal:  FEBS Lett       Date:  1990-01-15       Impact factor: 4.124

5.  Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines.

Authors:  S P Sheikh; M M O'Hare; O Tortora; T W Schwartz
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

6.  Neuropeptide Y receptor in vascular smooth muscle.

Authors:  Y Shigeri; S Mihara; M Fujimoto
Journal:  J Neurochem       Date:  1991-03       Impact factor: 5.372

7.  Neuropeptide Y stimulates inositol phospholipid hydrolysis in rat brain miniprisms.

Authors:  J Hinson; C Rauh; J Coupet
Journal:  Brain Res       Date:  1988-04-19       Impact factor: 3.252

8.  Conformational studies on the pancreatic polypeptide hormone family.

Authors:  I D Glover; D J Barlow; J E Pitts; S P Wood; I J Tickle; T L Blundell; K Tatemoto; J R Kimmel; A Wollmer; W Strassburger
Journal:  Eur J Biochem       Date:  1984-07-16

9.  Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction.

Authors:  J M Lundberg; A Hemsén; O Larsson; A Rudehill; A Saria; B B Fredholm
Journal:  Eur J Pharmacol       Date:  1988-01-05       Impact factor: 4.432

10.  Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro.

Authors:  C Wahlestedt; R Håkanson; C A Vaz; Z Zukowska-Grojec
Journal:  Am J Physiol       Date:  1990-03
View more
  64 in total

1.  Substitution of D-Trp32 in NPY destabilizes the binding transition state to the Y1 receptor site in SK-N-MC cell membranes.

Authors:  R Zand; C L Marcelo; R MacKenzie; L Georgic; D Maclean; W R Dunham
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

Review 2.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

3.  BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.

Authors:  Yvan Dumont; Pierrette Gaudreau; Manuela Mazzuferi; Daniel Langlois; Jean-Guy Chabot; Alain Fournier; Michele Simonato; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

4.  Neuropeptide Y and agouti-related peptide mediate complementary functions of hyperphagia and reduced energy expenditure in leptin receptor deficiency.

Authors:  Na Luo; Genevieve Marcelin; Shun Mei Liu; Gary Schwartz; Streamson Chua
Journal:  Endocrinology       Date:  2011-02-01       Impact factor: 4.736

Review 5.  Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction.

Authors:  Robin K Minor; Joy W Chang; Rafael de Cabo
Journal:  Mol Cell Endocrinol       Date:  2008-11-11       Impact factor: 4.102

6.  Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.

Authors:  M Tschöpl; R C Miller; J Pelton; J C Stoclet; B Bucher
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

7.  The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.

Authors:  Duc Quyen Chu; Helen M Cox; Soraia K P Costa; Herbert Herzog; Susan D Brain
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

8.  Production, characterization, and expression of neuropeptide Y by human pheochromocytoma.

Authors:  P deS Senanayake; J Denker; E L Bravo; R M Graham
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors.

Authors:  H Yan; J Yang; J Marasco; K Yamaguchi; S Brenner; F Collins; W Karbon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

10.  The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous receptor.

Authors:  I Lundell; M A Statnick; D Johnson; D A Schober; P Starbäck; D R Gehlert; D Larhammar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.